Stoichiometric parameters of HIV-1 entry

Virology

Volumn 474, Issue , 2015, Pages 1-9

  Zarr, Melissa ^a   Siliciano, Robert ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

CCR5; CD4; CXCR4; Entry; Env; Gp120; HIV 2; Relative infectivity

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIRUS RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MATHEMATICAL MODEL; NONHUMAN; RECEPTOR BINDING; STOICHIOMETRY; VIRION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS SPIKE; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMISTRY; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; MUTATION; PHYSIOLOGY; VIRUS GENE;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

ANTIGENS, CD4; GENES, VIRAL; HEK293 CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MODELS, BIOLOGICAL; MUTATION; RECEPTORS, HIV; VIRUS INTERNALIZATION;

EID: 84909608044     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.10.007     Document Type: Article

References (26)

1. Alkhatib G. The biology of CCR5 and CXCR4. Curr. Opin. HIV AIDS 2009, 4:96-103.
2. Babcock G.J., Mirzabekov T., Wojtowicz W., Sodroski J. Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes. J. Biol. Chem. 2001, 276:38433.
3. Berger E.A. A new classification for HIV-1. Nature 1988, 17:657-700.
4. Doranz B.J., Baik S.S.W., Doms R.W. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events. J. Virol. 1999, 73:10346-10358.
5. Herrera C., Klasse P.J., Kibler C.W., Michael E., Moore J.P., Beddows S. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex. J. Virol. 2006, 351:121-132.
6. Hoffman T.L., Canziani G., Jia L., Rucker J., Doms R.W. A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11215.
7. Kellam P., Larder BA. Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob. Agents Chemother. 1994, 38:23-30.
8. Klasse P.J. Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. J. Virol. 2007, 369:245-262.
9. Kuhmann S.E., Platt E.J., Kozak S.L., Kabat D. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1. J. Virol. 2000, 75(15):7005-7015.
10. LaBranche C.C., Galasso G., Moore J.P., Bolognesi D.P., Hirsch M.S., Hammer S.M. HIV fusion and its inhibition. Antiviral Res. 2001, 50:95-115.
11. Lee B., Sharron M., Montaner L.J., Weissman D., Doms R.W. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:5215-5220.
12. Magnus C., Regoes R.R. Estimating the stoichiometry of HIV neutralization. PLoS Comput. Biol. 2010, 6(3):e1000713.
13. Magnus C., Rusert P., Bonhoeffer S., Trkola A., Regoes R.R. Estimating the stoichiometry of human immunodeficiency virus entry. J. Virol. 2009, 83:1523-1531.
14. Moore J.P., Trkola A., Dragic T. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 1997, 9:551-562.
15. Moore J.P., Kitchen S.G., Pugach P., Zack J.A. Understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20:111-126.
16. Salzwedel K., Berger E.A. Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: a general property of the functional trimer. Retrovirology 2009, 6:75.
17. Schønning K., Lund O., Søgaard Lund O., Hansen J.E. Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1. J. Virol. 1999, 73:8364-8370.
18. Sougrat R., Bartesaghi A., Lifson J.D., Bennett A.E., Bess J.W., Zabransky D.J., Subramaniam S. Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry. PLoS Pathog. 2007, 4(5):e63. (3).
19. Wilen C.B., Tilton J.C., Doms R.W. Molecular mechanisms of HIV entry. Adv. Exp. Med. Biol. 2012, 726:223-242.
20. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384:179-183.
21. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280:1884-1888.
22. Yang X., Kurteva S., Lee S., Sodroski J. Stoichiometry of antibody neutralization of human immunodeficiency virus type 1. J. Virol. 2005, 79:3500-3508.
23. Yang X., Kurteva S., Ren X., Yang S.L., Sodroski J. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J. Virol. 2005, 79:12132-12147.
24. Yang X., Kurteva S., Ren X., Lee S., Sodroski J. Subunit stoichiometry of human immunodeficiency virus type 1 envelope glycoprotein trimers during virus entry into host cells. J. Virol. 2006, 80:4388-4395.
25. Zarr M.A. (2014): Relative Infectivity Data Set for figs. 3 and 4. LabArchives. http://dx.doi.org/10.6070/H4C53HS7.
26. Zhang H., Zhou Y., Alcock C., Kiefer T., Monie D., Siliciano J., Li Q., Pham P., Cofrancesco J., Persaud D., Siliciano R.F. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J. Virol. 2004, 78:1718-1729.